View in EDS HTML Full Text PDF Full Text

Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis.

Saved in:
Bibliographic Details
Title: Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis.
Authors: Bollo L; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Pareto D; Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain., Tagliani P; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Sceppacuercia S; Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain., Alberich M; Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain., Cabello S; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Carbonell P; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Villacieros-Álvarez J; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Cobo-Calvo À; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Tur C; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Arrambide G; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Carvajal R; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Castilló J; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Galan I; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Mongay-Ochoa N; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Pappolla A; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Midaglia L; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Rodriguez-Acevedo B; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Rio J; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Vilaseca A; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Zabalza A; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Comabella M; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Auger C; Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain., Tintoré M; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain., Sastre-Garriga J; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Rovira À; Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain., Montalban X; Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain., Vidal-Jordana A; Neurology department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Multiple Sclerosis Center of Catalonia (Cemcat), Barcelona, Spain.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Mar; Vol. 32 (3), pp. 279-288. Date of Electronic Publication: 2026 Jan 30.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-0970
DOI:10.1177/13524585251407976